Merck Announces 1200 Sales Jobs to be Eliminated
Pharmaceutical manufacturer giant Merck & Company Inc. announces more bad news with the elimination of 1,200 sales jobs in its US salesforce. This news comes after a decision last week from the FDA that issued a non-approvable letter for Cordaptive which was supposed to be Merck's newest cholesterol lowering drug. Also, Merck had been notified that immediate improvements must be made at one of their vaccine maufacturing plants. How much bad news can one company withstand in one month?
Amy Rose, a Merck spokeswoman, said the lay-offs represent about 15 percent of Merck's salesforce. The job cuts are part of a global restructuring plan announced in late 2005, meant to generate a up to $5 billion in savings through 2010.
Merck's earnings have been hurt by disappointing sales of its Vytorin cholesterol fighter since studies were released showing some diappointing results.
So far, the news has had almost no impact on Merck shares
Amy Rose, a Merck spokeswoman, said the lay-offs represent about 15 percent of Merck's salesforce. The job cuts are part of a global restructuring plan announced in late 2005, meant to generate a up to $5 billion in savings through 2010.
Merck's earnings have been hurt by disappointing sales of its Vytorin cholesterol fighter since studies were released showing some diappointing results.
So far, the news has had almost no impact on Merck shares
Welcome to
Open Networkers
Deep Power Searches & Tools
Sponsor area, sponsor us
ON Masterclasses & Book
Activity, respecting your privacy
We are idealists. The ON has no commercial goals, therefore we need your help
Please inform the Management of OpenNetworkers.info if a member if not acting upon our Code of Conduct and / or is spamming you using ON resources.
Get your Badge
© 2009 Created by Ray van den Bel
